Literature DB >> 11405596

Russell-Silver Syndrome in a Nigerian infant with intrauterine growth retardation.

A W Johnson1, O A Mokuolu.   

Abstract

Russell-Silver Syndrome (RSS) is a rare cause of pre-natal dwarfism, associated with recognizable dysmorphic features and limb asymmetry. The propositus was a term infant of unrelated Nigerian parents, whose 35-year-old mother had peri-conceptual haloperidol for schizophrenia. Anthropometric values suggested severe prenatal stunting in a term infant with asymmetric "head sparing" intrauterine growth retardation (IUGR). A syndromic consideration of Russell-Silver dwarfism was subsequently predicated on the distinctive dysmorphic craniofacial features of a triangular facial profile with a broad forehead and hypoplastic mandible, right upper and lower limb rhizomelia, clinodactyly of the little fingers, micro-penis, and (unilateral) cryptochidism. Routine care of a small-for-gestational-age infant was pursued, but postnatal growth remained slow (despite adequate caloric provision) until a parent-pressured discharge at 4 weeks. His subsequent demise was said to have occurred "suddenly" 2 weeks post-discharge. Despite the limitations posed by the local paucity of modern investigative tools for genetic disorders, the current case report underscores the diagnostic reality of RSS in a non-white African population. While emphasizing the need for a high index of diagnostic suspicion for congenital malformations and syndromic causes of IUGR in the African sub-region, we suspect a possible etiologic association of haloperidol embryopathy with RSS in the current case. The characteristic features, differential diagnoses, etiologic postulates/current cytogenetic and molecular genetic findings of RSS are fully reviewed in the discussion.

Entities:  

Mesh:

Year:  2001        PMID: 11405596      PMCID: PMC2593975     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  53 in total

Review 1.  Nontraditional inheritance.

Authors:  K D Austin; J G Hall
Journal:  Pediatr Clin North Am       Date:  1992-04       Impact factor: 3.278

2.  [Congenital glaucoma and the Silver-Russel syndrome].

Authors:  J B Saracco; G Jourdan; J Genevet; A Meiffret; G Farnarier
Journal:  Bull Soc Ophtalmol Fr       Date:  1971-01

3.  Plasma growth hormone determination in the Silver-Russell syndrome.

Authors:  R Eeckels; R Wolter
Journal:  Helv Paediatr Acta       Date:  1970-10

4.  A new skeletal dysplasia syndrome with rhizomelia of the humeri and other malformations.

Authors:  D Urbach; M Hertz; M Shein; R M Goodman; M Shine
Journal:  Clin Genet       Date:  1986-01       Impact factor: 4.438

Review 5.  [Diagnostic value of café-au-lait spots (author's transl)].

Authors:  J P Ortonne; E Brocard; D Floret; H Perrot; J Thivolet
Journal:  Ann Dermatol Venereol       Date:  1980-04       Impact factor: 0.777

6.  Human PEG1/MEST, an imprinted gene on chromosome 7.

Authors:  S Kobayashi; T Kohda; N Miyoshi; Y Kuroiwa; K Aisaka; O Tsutsumi; T Kaneko-Ishino; F Ishino
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

7.  Surgical treatment of popliteal artery entrapment syndrome: a ten-year experience.

Authors:  L di Marzo; A Cavallaro; V Sciacca; A Mingoli; A Tamburelli
Journal:  Eur J Vasc Surg       Date:  1991-02

8.  Human EGFR, a candidate gene for the Silver-Russell syndrome, is biallelically expressed in a wide range of fetal tissues.

Authors:  E L Wakeling; S N Abu-Amero; P Stanier; M A Preece; G E Moore
Journal:  Eur J Hum Genet       Date:  1998 Mar-Apr       Impact factor: 4.246

9.  The relative contribution of prematurity and fetal growth retardation to low birth weight in developing and developed societies.

Authors:  J Villar; J M Belizán
Journal:  Am J Obstet Gynecol       Date:  1982-08-01       Impact factor: 8.661

10.  Silver-Russell syndrome. Observations in 20 patients.

Authors:  V Angehrn; M Zachmann; A Prader
Journal:  Helv Paediatr Acta       Date:  1979-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.